Trade Summary

6 days ago, Krasney Karen, serving as EVP, GENERAL COUNSEL at CAPRICOR THERAPEUTICS, INC. (CAPR), sold 24,100 shares at $30.38 per share, for a total transaction value of $732,158.00. Following this transaction, Krasney Karen now holds 30,547 shares of CAPR.

This sale represents a 44.10% decrease in Krasney Karen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 (accepted Jun 29, 9:30 PM ET), 5 days after the trade was made.

CAPRICOR THERAPEUTICS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.